The Effect of Motivational Interviewing on Diabetes Self-Management in Diabetic Patients
1 other identifier
interventional
80
1 country
1
Brief Summary
Diabetes is a chronic metabolic disorder characterized by high blood sugar due to problems with insulin production or function. Its prevalence has increased significantly in recent decades due to sedentary lifestyles, unhealthy diets, and increasing obesity rates. Type 2 diabetes, in particular, is a major global and national health problem with projections showing that it continues to grow. Effective diabetes management requires patients to adopt healthy behaviors such as following a diet plan, monitoring blood sugar, increasing physical activity, and avoiding risky habits such as smoking. Inadequate adherence to treatment can lead to serious complications such as cardiovascular disease and kidney damage, which can be a burden to patients, families, and healthcare systems. Motivational interviewing, a patient-centered approach, helps individuals overcome resistance to behavioral change. This study was designed experimentally to determine the effect of motivational interviewing on diabetes self-management in patients with type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 6, 2024
CompletedFirst Posted
Study publicly available on registry
December 10, 2024
CompletedStudy Start
First participant enrolled
December 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2026
ExpectedDecember 10, 2024
December 1, 2024
1 year
December 6, 2024
December 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diabetes Self-Management
Type 2 Diabetes Self-Management Scale
6 months
Secondary Outcomes (1)
HbA1c
6 months
Study Arms (2)
Motivational Interviewing
EXPERIMENTALMotivational interviews will be conducted with diabetic patients for 6 months. Patients will be trained before starting the interviews.
Control
EXPERIMENTALNo application will be made. Routine follow-ups will be made.
Interventions
Motivational interviews will be conducted with diabetic patients for 6 months. Patients will be trained before starting the interviews.
Eligibility Criteria
You may qualify if:
- Individuals who agree to participate in the study voluntarily, can speak and understand Turkish, can communicate comfortably, have no hearing, comprehension or vision problems, are literate, use a smartphone, have Type 2 Diabetes and have HbA1c ≥ 7% will be included in the study.
You may not qualify if:
- Patients with cognitive dysfunction and those using antipsychotic medication will not be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istanbul Beykent University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
December 6, 2024
First Posted
December 10, 2024
Study Start
December 20, 2024
Primary Completion
December 20, 2025
Study Completion (Estimated)
June 20, 2026
Last Updated
December 10, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR